Cellular and Molecular Inflammatory Mechanisms Leading to Bone Resorption in Peri-implantitis Vs Periodontitis
- Conditions
- Peri-ImplantitisPeriodontitis
- Interventions
- Procedure: Open Flap DebridementProcedure: Crown lengthening
- Registration Number
- NCT02664675
- Lead Sponsor
- University of Paris 5 - Rene Descartes
- Brief Summary
Recent data found that peri-implantitis may differ from periodontitis at the histological level in terms of extent and composition of the cellular components. From human biopsies, it has been shown a deeper apical extension of the inflammatory cell infiltrate and a larger proportion of granulocytes and macrophages in peri-implantitis lesions compared to periodontitis lesions. Following experimental peri-implantitis, it has been observed a continuing bone loss around dental implants after ligature removal; whereas, such a progression was not observed around teeth after cessation of the experimental periodontitis. The factors influencing the recruitment and the activation of osteoclasts in both diseases have not been compared yet.
Hypothesis : The more rapid and more severe alveolar bone destruction occurring in peri-implantitis compared to periodontitis is due at least in part to differences in the inflammatory process in these diseases.
Aim: to study the cytokine profile produced by gingival explants from periodontitis or peri-implantitis sites and to test the consequences on alteration of bone remodelling activity using in vitro approach.
Materials and methods The investigators will establish a collection of human gingival samples from patients undergoing surgical treatment of periodontitis or peri-implantitis. The investigators will test pro-inflammatory cytokines and chemokines release and consequences on osteoclast differentiation and activity.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 33
-
Beneficiary by national health insurance
-
Age: over 18 year-old
-
Non smoking
-
Good health
---For the periimplantitis group:
-
patients formerly treated with a non surgical procedure without antibiotics with at least one functional dental implant with at least on pocket deeper than 5 mm with bleeding on probing and radiographical alveolar bone loss.
---For the periodontitis group:
-
patients formerly treated with a non surgical procedure without antibiotics for a generalized severe chronic periodontitis (in accord to Armitage 2009) and needing a resective surgical procedure (periodontal pockets deeper than 5 mm with bleeding on probing)
---For the healthy group:
-
patients with good health without periodontal or peri implant disease needing gingivectomy (crown lengthening, esthetic surgery)
- Smokers
- Patients treated with antibiotics or NSAID during the last 3 months
- Patients suffering from a chronic infectious, inflammatory or auto-immune disease (non equilibrated diabetes mellitus, rheumatoid arthritis, spondylarthrosis, Gougerot-Sjögren, Crohn, Behcet, Horton, obesity, chronic end renal disease, cardiopathies....)
- Pregnant women
- For the healthy group : bleeding on probing on the site.
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description Periimplantitis Open Flap Debridement patients formerly treated with a non surgical procedure without antibiotics with at least one functional dental implant with at least on pocket deeper than 5 mm with bleeding on probing and radiographical alveolar bone loss. These patient will be treated by open flap debridement nd the granulation tissue xill be harvested for analysis. Periodontitis Open Flap Debridement patients formerly treated with a non surgical procedure without antibiotics for a generalized severe chronic periodontitis (in accord to Armitage 2009) and needing a resective surgical procedure (periodontal pockets deeper than 5 mm with bleeding on probing) These patient will be treated by open flap debridement nd the granulation tissue xill be harvested for analysis. Healthy patient Crown lengthening healthy patients needing crown lengthening allowing collection of gingival explants
- Primary Outcome Measures
Name Time Method Interleukine 17 (IL-17) releasing from periodontitis and peri-implantitis gingival samples 24 hours of incubation Interleukine 17 (IL-17) releasing in the medium from harvested granulation tissue from periodontitis, peri-implantitis and healthy patients will be determine by ELISA test 24 hours after the beginning of the culture.
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (2)
Hospital Rotschild
🇫🇷Paris, France
Hospital Charles Foix APHP
🇫🇷Ivry Sur Seine, France